Hongjiao Xiang

768 total citations
21 papers, 537 citations indexed

About

Hongjiao Xiang is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hongjiao Xiang has authored 21 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hongjiao Xiang's work include Liver Disease Diagnosis and Treatment (9 papers), Metabolomics and Mass Spectrometry Studies (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Hongjiao Xiang is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Metabolomics and Mass Spectrometry Studies (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Hongjiao Xiang collaborates with scholars based in China, Hong Kong and United States. Hongjiao Xiang's co-authors include Tao Wu, Yifei Lü, Guang Ji, Junmin Wang, Mingmei Shao, Junmin Wang, Peilun Ding, Tao Wu, Yifan Xu and Peiyong Zheng and has published in prestigious journals such as Journal of Ethnopharmacology, Frontiers in Pharmacology and Biomedicine & Pharmacotherapy.

In The Last Decade

Hongjiao Xiang

21 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongjiao Xiang China 13 285 110 97 64 60 21 537
Zhao Wu China 13 350 1.2× 72 0.7× 96 1.0× 131 2.0× 46 0.8× 38 638
Xuemei Xian China 3 278 1.0× 110 1.0× 101 1.0× 48 0.8× 91 1.5× 8 650
Huimin Bian China 11 234 0.8× 53 0.5× 79 0.8× 49 0.8× 50 0.8× 19 564
Chengyong Tang China 12 319 1.1× 140 1.3× 209 2.2× 63 1.0× 84 1.4× 21 695
Fang Yu China 18 409 1.4× 72 0.7× 164 1.7× 66 1.0× 91 1.5× 31 829
Ziyang Cui China 3 266 0.9× 100 0.9× 77 0.8× 42 0.7× 94 1.6× 4 668
Yakun Yang China 15 192 0.7× 101 0.9× 64 0.7× 85 1.3× 58 1.0× 46 590
Jiangyang Chi China 12 424 1.5× 145 1.3× 66 0.7× 45 0.7× 89 1.5× 20 742
Bong Jun Cho South Korea 14 324 1.1× 52 0.5× 106 1.1× 112 1.8× 35 0.6× 19 610

Countries citing papers authored by Hongjiao Xiang

Since Specialization
Citations

This map shows the geographic impact of Hongjiao Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjiao Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjiao Xiang more than expected).

Fields of papers citing papers by Hongjiao Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjiao Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjiao Xiang. The network helps show where Hongjiao Xiang may publish in the future.

Co-authorship network of co-authors of Hongjiao Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjiao Xiang. A scholar is included among the top collaborators of Hongjiao Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjiao Xiang. Hongjiao Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Caiyun, Hongjiao Xiang, Junmin Wang, et al.. (2023). Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology. Journal of Ethnopharmacology. 317. 116676–116676. 3 indexed citations
2.
Wang, Junmin, Yifei Lü, Caiyun Zhang, et al.. (2023). Qinggan Huoxue Recipe attenuates Alcoholic Liver Disease by suppressing PI3K/AKT signaling pathway based on network pharmacology. International Journal of Medical Sciences. 20(3). 346–358. 4 indexed citations
3.
Wang, Yirong, Junmin Wang, Hongjiao Xiang, et al.. (2022). Recent update on application of dihydromyricetin in metabolic related diseases. Biomedicine & Pharmacotherapy. 148. 112771–112771. 36 indexed citations
4.
Lü, Yifei, Mingmei Shao, Hongjiao Xiang, et al.. (2022). Qinggan Huoxue Recipe Alleviates Alcoholic Liver Injury by Suppressing Endoplasmic Reticulum Stress Through LXR-LPCAT3. Frontiers in Pharmacology. 13. 824185–824185. 9 indexed citations
5.
Shao, Mingmei, Yifei Lü, Hongjiao Xiang, et al.. (2022). Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine. Frontiers in Pharmacology. 13. 971561–971561. 7 indexed citations
6.
Lü, Yifei, Mingmei Shao, Caiyun Zhang, et al.. (2022). Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism. Frontiers in Pharmacology. 13. 946360–946360. 13 indexed citations
7.
Wang, Junmin, Ying Gao, Hongjiao Xiang, et al.. (2022). Metabolomics window into the diagnosis and treatment of inflammatory bowel disease in recent 5 years. International Immunopharmacology. 113(Pt B). 109472–109472. 7 indexed citations
8.
Xiang, Hongjiao, et al.. (2022). LCAT- targeted therapies: Progress, failures and future. Biomedicine & Pharmacotherapy. 147. 112677–112677. 34 indexed citations
9.
Shao, Mingmei, Hongjiao Xiang, Hao Lü, et al.. (2022). Candidate metabolite markers of peripheral neuropathy in Chinese patients with type 2 diabetes.. PubMed. 14(8). 5420–5440. 12 indexed citations
10.
Wu, Tao, Xiaojiao Zheng, Ming Yang, et al.. (2022). Serum Amino Acid Profiles Predict the Development of Hepatocellular Carcinoma in Patients with Chronic HBV Infection. ACS Omega. 7(18). 15795–15808. 15 indexed citations
11.
Ding, Peilun, Ying Gao, Junmin Wang, et al.. (2022). Progress and challenges of multidrug resistance proteins in diseases.. PubMed. 12(10). 4483–4501. 8 indexed citations
12.
Xiang, Hongjiao, Mingmei Shao, Yifei Lü, et al.. (2021). Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway. Frontiers in Pharmacology. 12. 690736–690736. 39 indexed citations
13.
Wang, Junmin, Hongjiao Xiang, Yifei Lü, Tao Wu, & Guang Ji. (2021). New progress in drugs treatment of diabetic kidney disease. Biomedicine & Pharmacotherapy. 141. 111918–111918. 45 indexed citations
14.
Xiang, Hongjiao, et al.. (2021). Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. Journal of Cancer. 12(19). 5929–5937. 5 indexed citations
15.
Chen, Xinyi, Hongjiao Xiang, Shiyu Yu, Yifei Lü, & Tao Wu. (2021). Research progress in the role and mechanism of Cadherin-11 in different diseases. Journal of Cancer. 12(4). 1190–1199. 27 indexed citations
16.
Wang, Junmin, Hongjiao Xiang, Yifei Lü, & Tao Wu. (2021). Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review). International Journal of Molecular Medicine. 47(4). 77 indexed citations
17.
Xiang, Hongjiao, et al.. (2021). Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase. Biomedicine & Pharmacotherapy. 139. 111610–111610. 46 indexed citations
18.
Wang, Junmin, Hongjiao Xiang, Yifei Lü, Tao Wu, & Guang Ji. (2021). The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression.. American Journal of Cancer Research. 11(6). 2477–2494. 49 indexed citations
19.
Xiang, Hongjiao, Yifei Lü, Mingmei Shao, & Tao Wu. (2020). Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases. Journal of Cancer. 11(12). 3519–3535. 33 indexed citations
20.
Lü, Yifei, Mingmei Shao, Hongjiao Xiang, et al.. (2020). Integrative transcriptomics and metabolomics explore the mechanism of kaempferol on improving nonalcoholic steatohepatitis. Food & Function. 11(11). 10058–10069. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhao Wu Breakdown of academic impact, for papers by Xuemei Xian Breakdown of academic impact, for papers by Huimin Bian Breakdown of academic impact, for papers by Chengyong Tang Breakdown of academic impact, for papers by Fang Yu Breakdown of academic impact, for papers by Ziyang Cui Breakdown of academic impact, for papers by Yakun Yang Breakdown of academic impact, for papers by Jiangyang Chi Breakdown of academic impact, for papers by Bong Jun Cho
Rankless by CCL
2026